Early intervention studies in infants and preschool children with cystic fibrosis: Are we ready?

European Respiratory Journal

Volumn 42, Issue 2, 2013, Pages 527-538

  Stick, Stephen ^a   Tiddens, Harm ^b,c   Aurora, Paul ^d   Gustafsson, Per ^e   Ranganathan, Sarath ^f   Robinson, Paul ^g   Rosenfeld, Margaret ^h   Sly, Peter ^i,j   Ratjen, Felix ^k  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^e CENTRAL HOSPITAL   (Sweden)

^f ROYAL CHILDREN'S HOSPITAL   (Australia)

^g CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^h SEATTLE CHILDREN S HOSPITAL   (United States)

ⁱ UNIVERSITY OF QUEENSLAND   (Australia)

^j ROYAL CHILDREN'S HOSPITAL   (Australia)

^k UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; C REACTIVE PROTEIN; DORNASE ALFA; TOBRAMYCIN;

BREATHING DISORDER; BRONCHIECTASIS; CHILDHOOD DISEASE; COMPUTER ASSISTED TOMOGRAPHY; EARLY INTERVENTION; FUNCTIONAL RESIDUAL CAPACITY; HUMAN; INFANT DISEASE; LUNG FIBROSIS; LUNG FUNCTION TEST; LUNG INJURY; LUNG LAVAGE; MULTIPLE BREATH INERT GAS WASHOUT; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAISED VOLUME RAPID THORACOABDOMINAL COMPRESSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESPIRATORY TRACT DISEASE; REVIEW; SCORING SYSTEM; SPIROMETRY; THORAX RADIOGRAPHY;

BRONCHOALVEOLAR LAVAGE; CHILD, PRESCHOOL; CYSTIC FIBROSIS; HUMANS; INFANT; INFLAMMATION; INTERVENTION STUDIES; LUNG; LUNG DISEASES; RESPIRATION; RESPIRATORY FUNCTION TESTS; SPIROMETRY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84880040035     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00108212     Document Type: Review

References (84)

1. Pillarisetti N, Williamson E, Linnane B, et al. Infection, inflammation, and lung function decline in infants with cystic fibrosis. Am J Respir Crit Care Med 2011; 184: 75-81.
2. Sermet-Gaudelus I, Mayell SJ, Southern KW. Guidelines on the early management of infants diagnosed with cystic fibrosis following newborn screening. J Cyst Fibros 2010; 9: 323-329.
3. Ramsey BW, Davies J, McElvaney NG, et al. A CFTR potentiator in patients with cystic fibrosis and the G551D mutation. N Engl J Med 2011; 365: 1663-1672.
4. Kang EY, Miller RR, Mu?ller NL. Bronchiectasis: comparison of preoperative thin-section CT and pathologic findings in resected specimens. Radiology 1995; 195: 649-654.
5. Hansell DM. Bronchiectasis. Radiol Clin North Am 1998; 36: 107-128.
6. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003; 168: 918-951.
7. Bedrossian CW, Greenberg SD, Singer DB, et al. The lung in cystic fibrosis: a quantitative study including prevalence of pathologic findings among different age groups. Hum Pathol 1976; 7: 195-204.
8. Stick SM, Brennan S, Murray C, et al. Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr 2009; 155: 623-628.
9. Long FR. High-resolution computed tomography of the lung in children with cystic fibrosis: technical factors. Proc Am Thorac Soc 2007; 4: 306-309.
10. Mart?́nez TM, Llapur CJ, Williams TH, et al. High-resolution computed tomography imaging of airway disease in infants with cystic fibrosis. Am J Respir Crit Care Med 2005; 172: 1133-1138.
11. Sly PD, Brennan S, Gangell C, et al. Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med 2009; 180: 146-152.
12. Loeve M, Hop WC, de Bruijne M, et al. Chest computed tomography scores are predictive of survival in patients with cystic fibrosis awaiting lung transplantation. Am J Respir Crit Care Med 2012; 185: 1096-1103.
13. Davis SD, Fordham LA, Brody AS, et al. Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis. Am J Respir Crit Care Med 2007; 175: 943-950.
14. Mott LS, Park J, Murray CP, et al. Progression of early structural lung disease in young children with cystic fibrosis assessed using CT. Thorax 2012; 67: 509-516.
15. Brody AS, Klein JS, Molina PL, et al. High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests. J Pediatr 2004; 145: 32-38.
16. Wainwright CE, Vidmar S, Armstrong DS, et al. Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial. JAMA 2011; 306: 163-171.
17. de Jong PA, Nakano Y, Lequin MH, et al. Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis. Eur Respir J 2004; 23: 93-97.
18. de Jong PA, Lindblad A, Rubin L, et al. Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis. Thorax 2006; 61: 80-85.
19. Shah RM, Sexauer W, Ostrum BJ, et al. High-resolution CT in the acute exacerbation of cystic fibrosis: evaluation of acute findings, reversibility of those findings, and clinical correlation. AJR Am J Roentgenol 1997; 169: 375-380.
20. Brody AS, Molina PL, Klein JS, et al. High-resolution computed tomography of the chest in children with cystic fibrosis: support for use as an outcome surrogate. Pediatr Radiol 1999; 29: 731-735.
21. Robinson TE, Goris ML, Zhu HJ, et al. Dornase alfa reduces air trapping in children with mild cystic fibrosis lung disease: a quantitative analysis. Chest 2005; 128: 2327-2335.
22. Robinson TE, Leung AN, Northway WH, et al. Composite spirometric-computed tomography outcome measure in early cystic fibrosis lung disease. Am J Respir Crit Care Med 2003; 168: 588-593.
23. Nasr SZ, Kuhns LR, Brown RW, et al. Use of computerized tomography and chest x-rays in evaluating efficacy of aerosolized recombinant human DNase in cystic fibrosis patients younger than age years: a preliminary study. Pediatr Pulmonol 2001; 31: 377-382.
24. Nasr SZ, Gordon D, Sakmar E, et al. High resolution computerized tomography of the chest and pulmonary function testing in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis patients. Pediatr Pulmonol 2006; 41: 1129-1137.
25. Nasr SZ, Sakmar E, Christodoulou E, et al. The use of high resolution computerized tomography (HRCT) of the chest in evaluating the effect of tobramycin solution for inhalation in cystic fibrosis lung disease. Pediatr Pulmonol 2010; 45: 440-449.
26. Long FR, Williams RS, Adler BH, et al. Comparison of quiet breathing and controlled ventilation in the highresolution CT assessment of airway disease in infants with cystic fibrosis. Pediatr Radiol 2005; 35: 1075-1080.
27. de Jong PA, Mayo JR, Golmohammadi K, et al. Estimation of cancer mortality associated with repetitive computed tomography scanning. Am J Respir Crit Care Med 2006; 173: 199-203.
28. de Jong PA, Tiddens HA, Lequin MH, et al. Estimation of the radiation dose from CT in cystic fibrosis. Chest 2008; 133: 1289-1291.
29. Aurora P, Bush A, Gustafsson P, et al. Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis. Am J Respir Crit Care Med 2005; 171: 249-256.
30. Gustafsson PM, Aurora P, Lindblad A. Evaluation of ventilation maldistribution as an early indicator of lung disease in children with cystic fibrosis. Eur Respir J 2003; 22: 972-979.
31. Lum S, Gustafsson P, Ljungberg H, et al. Early detection of cystic fibrosis lung disease: multiple-breath washout versus raised volume tests. Thorax 2007; 62: 341-347.
32. Robinson PD, Goldman MD, Gustafsson PM. Inert gas washout: theoretical background and clinical utility in respiratory disease. Respiration 2009; 78: 339-355.
33. Haidopoulou K, Lum S, Turcu S, et al. Alveolar LCI versus standard LCI in detecting early CF lung disease. Respir Physiol Neurobiol 2012; 180: 247-251.
34. Downie SR, Salome CM, Verbanck S, et al. Ventilation heterogeneity is a major determinant of airway hyperresponsiveness in asthma, independent of airway inflammation. Thorax 2007; 62: 684-689.
35. Fuchs SI, Sturz J, Junge S, et al. A novel sidestream ultrasonic flow sensor for multiple breath washout in children. Pediatr Pulmonol 2008; 43: 731-738.
36. Green K, Buchvald FF, Marthin JK, et al. Ventilation inhomogeneity in children with primary ciliary dyskinesia. Thorax 2012; 67: 49-53.
37. Gustafsson PM. Peripheral airway involvement in CF and asthma compared by inert gas washout. Pediatr Pulmonol 2007; 42: 168-176.
38. Gustafsson PM, De Jong PA, Tiddens HA, et al. Multiple-breath inert gas washout and spirometry versus structural lung disease in cystic fibrosis. Thorax 2008; 63: 129-134.
39. Owens CM, Aurora P, Stanojevic S, et al. Lung Clearance Index and HRCT are complementary markers of lung abnormalities in young children with CF. Thorax 2011; 66: 481-488.
40. Hall GL, Logie KM, Parsons F, et al. Air trapping on chest CT is associated with worse ventilation distribution in infants with cystic fibrosis diagnosed following newborn screening. PLoS One 2011; 6: e23932.
41. Kieninger E, Singer F, Fuchs O, et al. Long-term course of lung clearance index between infancy and school-age in cystic fibrosis subjects. J Cyst Fibros 2011; 10: 487-490.
42. Aurora P, Stanojevic S, Wade A, et al. Lung clearance index at years predicts subsequent lung function in children with cystic fibrosis. Am J Respir Crit Care Med 2011; 183: 752-758.
43. Amin R, Subbarao P, Jabar A, et al. Hypertonic saline improves the LCI in paediatric CF patients with normal lung function. Thorax 2010; 65: 379-383.
44. Fuchs SI, Gappa M. Lung clearance index: clinical and research applications in children. Paediatr Respir Rev 2011; 12: 264-270.
45. Lum S, Stocks J, Stanojevic S, et al. Age and height dependence of lung clearance index and functional residual capacity. Eur Respir J 2012; 41: 1371-1377.
46. Fuchs SI, Ellemunter H, Eder J, et al. Feasibility and variability of measuring the Lung Clearance Index in a multicenter setting. Pediatr Pulmonol 2012; 47: 649-657.
47. Singer F, Houltz B, Latzin P, et al. A realistic validation study of a new nitrogen multiple-breath washout system. PLoS One 2012; e36083.
48. Houltz B, Green K, Lindblad A, et al. Tidal N2 washout ventilation inhomogeneity indices in a reference population aged 7-70 years. Eur Respir J 2012; 40: Suppl. 56, 694s.
49. Anastassopoulou CG, Fuchs BB, Mylonakis E. Caenorhabditis elegans-based model systems for antifungal drug discovery. Curr Pharm Des 2011; 17: 1225-1233.
50. Robinson P, Latzin P, Verbanck S, et al. Guidelines for inert gas washout measurement using multiple and single breath tests. Eur Respir J 2013; 41: 507-513.
51. Turner DJ, Stick SM, Lesouef KL, et al. A new technique to generate and assess forced expiration from raised lung volume in infants. Am J Respir Crit Care Med 1995; 151: 1441-1450.
52. ATS/ERS statement: raised volume forced expirations in infants: guidelines for current practice. Am J Respir Crit Care Med 2005 172: 1463-1471.
53. Loland L, Bisgaard H. Feasibility of repetitive lung function measurements by raised volume rapid thoracoabdominal compression during methacholine challenge in young infants. Chest 2008; 133: 115-122.
54. Davis SD, Rosenfeld M, Kerby GS, et al. Multicenter evaluation of infant lung function tests as cystic fibrosis clinical trial endpoints. Am J Respir Crit Care Med 2010; 182: 1387-1397.
55. Mallol J, Aguirre VL, Wandalsen G. Variability of the raised volume rapid thoracic compression technique in infants with recurrent wheezing. Allergol Immunopathol (Madr) 2005; 33: 74-79.
56. Ranganathan SC, Hoo AF, Lum SY, et al. Exploring the relationship between forced maximal flow at functional residual capacity and parameters of forced expiration from raised lung volume in healthy infants. Pediatr Pulmonol 2002; 33: 419-428.
57. Jones M, Castile R, Davis S, et al. Forced expiratory flows and volumes in infants. Normative data and lung growth. Am J Respir Crit Care Med 2000; 161: 353-359.
58. Lum S, Hoo AF, Hulskamp G, et al. Potential misinterpretation of infant lung function unless prospective healthy controls are studied. Pediatr Pulmonol 2010; 45: 906-913.
59. Gappa M, Ranganathan SC, Stocks J. Lung function testing in infants with cystic fibrosis: lessons from the past and future directions. Pediatr Pulmonol 2001; 32: 228-245.
60. Ranganathan SC, Bush A, Dezateux C, et al. Relative ability of full and partial forced expiratory maneuvers to identify diminished airway function in infants with cystic fibrosis. Am J Respir Crit Care Med 2002; 166: 1350-1357.
61. Linnane BM, Hall GL, Nolan G, et al. Lung function in infants with cystic fibrosis diagnosed by newborn screening. Am J Respir Crit Care Med 2008; 178: 1238-1244.
62. Ranganathan SC, Stocks J, Dezateux C, et al. The evolution of airway function in early childhood following clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med 2004; 169: 928-933.
63. Kozlowska WJ, Bush A, Wade A, et al. Lung function from infancy to the preschool years after clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med 2008; 178: 42-49.
64. Harrison AN, Regelmann WE, Zirbes JM, et al. Longitudinal assessment of lung function from infancy to childhood in patients with cystic fibrosis. Pediatr Pulmonol 2009; 44: 330-339.
65. Peterson-Carmichael SL, Harris WT, Goel R, et al. Association of lower airway inflammation with physiologic findings in young children with cystic fibrosis. Pediatr Pulmonol 2009; 44: 503-511.
66. Dellon EP, Donaldson SH, Johnson R, et al. Safety and tolerability of inhaled hypertonic saline in young children with cystic fibrosis. Pediatr Pulmonol 2008; 43: 1100-1106.
67. Subbarao P, Balkovec S, Solomon M, et al. Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis. Pediatr Pulmonol 2007; 42: 471-146.
68. Pittman JE, Johnson RC, Davis SD. Improvement in pulmonary function following antibiotics in infants with cystic fibrosis. Pediatr Pulmonol 2012; 47: 441-446.
69. Rosenfeld M, Ratjen F, Brumback L, et al. Inhaled hypertonic saline in infants and children younger than years with cystic fibrosis: the ISIS randomized controlled trial. JAMA 2012; 307: 2269-2277.
70. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-338.
71. Beydon N, Davis SD, Lombardi E, et al. An official American Thoracic Society/European Respiratory Society statement: pulmonary function testing in preschool children. Am J Respir Crit Care Med 2007; 175: 1304-1345.
72. Aurora P, Gustafsson P, Bush A, et al. Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis. Thorax 2004; 59: 1068-1073.
73. Neve V, Edme JL, Devos P, et al. Spirometry in 3-5-year-old children with asthma. Pediatr Pulmonol 2006; 41: 735-743.
74. Stanojevic S, Wade A, Stocks J, et al. Reference ranges for spirometry across all ages: a new approach. Am J Respir Crit Care Med 2008; 177: 253-260.
75. Stanojevic S, Wade A, Cole TJ, et al. Spirometry centile charts for young Caucasian children: the Asthma UK Collaborative Initiative. Am J Respir Crit Care Med 2009; 180: 547-552.
76. Marostica PJ, Weist AD, Eigen H, et al. Spirometry in 3- to 6-year-old children with cystic fibrosis. Am J Respir Crit Care Med 2002; 166: 67-71.
77. Vilozni D, Bentur L, Efrati O, et al. Spirometry in early childhood in cystic fibrosis patients. Chest 2007; 131: 356-361.
78. Kerby GS, Rosenfeld M, Ren CL, et al. Lung function distinguishes preschool children with CF from healthy controls in a multi-center setting. Pediatr Pulmonol 2012; 47: 597-605.
79. Stick SM, Brennan S, Murray C, et al. Bronchiectasis in infants and preschool children diagnosed with cystic fibrosis after newborn screening. J Pediatr 2009; 155: 623-628e1.
80. Rosenfeld M, Emerson J, Accurso F, et al. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol 1999; 28: 321-328.
81. de Blic J, Midulla F, Barbato A, et al. Bronchoalveolar lavage in children. Eur Respir J 2000; 15: 217-231.
82. Treggiari MM, Retsch-Bogart G, Mayer-Hamblett N, et al. Comparative efficacy and safety of randomized regimens to treat early Pseudomonas aeruginosa infection in children with cystic fibrosis. Arch Pediatr Adolesc Med 2011; 165: 847-856.
83. Saiman L, Anstead M, Mayer-Hamblett N, et al. Effect of azithromycin on pulmonary function in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 2010; 303: 1707-1015.
84. Ratjen F, Saiman L, Mayer-Hamblett N, et al. Effect of azithromycin on systemic markers of inflammation in cystic fibrosis patients uninfected with Pseudomonas aeruginosa. Chest 2012; 142: 1259-1266.